Home/Filings/4/0001562180-23-000224
4//SEC Filing

Vasista Vittal 4

Accession 0001562180-23-000224

CIK 0001590877other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:06 PM ET

Size

9.5 KB

Accession

0001562180-23-000224

Insider Transaction Report

Form 4
Period: 2023-01-03
Vasista Vittal
See Remarks
Transactions
  • Award

    Stock Options (Right to buy)

    2023-01-03+66,23366,233 total
    Exercise: $22.25Exp: 2033-01-03Common Stock (66,233 underlying)
  • Tax Payment

    Common Stock

    2023-01-03$22.68/sh1,333$30,232133,827 total
  • Award

    Common Stock

    2023-01-03+46,174180,001 total
Footnotes (3)
  • [F1]Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.
  • [F2]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.
  • [F3]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001652827

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:06 PM ET
Size
9.5 KB